Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]
Xiao P +8 more
europepmc +1 more source
Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]
Yang L, Chen G, Lyu Z.
europepmc +1 more source
Therapeutic Target Mapping to Advance Drug Repurposing for Cardiovascular Disease: A Perspective from an Explanted Heart Biobank. [PDF]
Ng C +11 more
europepmc +1 more source
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Efficacy of Subcutaneous Firsekibart in Gout: A Phase Ib/II Clinical Trial. [PDF]
Xue Y +25 more
europepmc +1 more source
Pharmacologic management of renal involvement in monogenic autoinflammatory diseases. [PDF]
Fayed A +4 more
europepmc +1 more source
Molecular cancer prevention: Intercepting disease. [PDF]
Grieco C, Pandya T, Swanton C.
europepmc +1 more source
Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology. [PDF]
Wu H, Meng X, Li L, Zhang C.
europepmc +1 more source
Neonatal-onset multisystem inflammatory disease caused by a <i>de novo NLRP3</i> gene mutation: a case report and literature review. [PDF]
Zhao L, Zeng L, Yuan W.
europepmc +1 more source
The 14-protein lung cancer signature: questions of prediction, specificity, and causality
Sud A, Houlston R.
europepmc +1 more source

